We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Innoviva
INVA
$1.58B
| $22.1K | ﹤0.01% |
975
+15
| +2% | +$343 |
|
1877
Hormel Foods
HRL
$13.9B
| $22.1K | ﹤0.01% |
892
+530
| +146% | +$11.8K |
|
|
KREF
1878
KKR Real Estate Finance Trust
KREF
$472M
| $22.1K | ﹤0.01% |
3,229
+2,784
| +626% | +$18.4K |
|
1879
Herc Holdings
HRI
$5.43B
| $22.1K | ﹤0.01% |
154
-2
| -1% | -$258 |
|
1880
MasterCraft Boat Holdings
MCFT
$588M
| $22K | ﹤0.01% |
851
-31
| -4% | -$721 |
|
1881
Intapp
INTA
$2.12B
| $21.9K | ﹤0.01% |
870
-2,230
| -72% | -$50.8K |
|
1882
CleanSpark
CLSK
$3.73B
| $21.8K | ﹤0.01% |
1,501
+247
| +20% | +$3.49K |
|
1883
Nice
NICE
$5.29B
| $21.7K | ﹤0.01% |
239
-350
| -59% | -$33.9K |
|
1884
Mercury Insurance
MCY
$5.94B
| $21.6K | ﹤0.01% |
203
| – | – |
|
1885
York Water
YORW
$505M
| $21.6K | ﹤0.01% |
706
+142
| +25% | +$4.26K |
|
1886
Oscar Health
OSCR
$8.5B
| $21.6K | ﹤0.01% |
+757
| New | +$16.3K |
|
1887
Skyward Specialty Insurance
SKWD
$2.45B
| $21.6K | ﹤0.01% |
370
+256
| +225% | +$12.1K |
|
1888
Golar LNG
GLNG
$4.95B
| $21.6K | ﹤0.01% |
433
| – | – |
|
1889
iShares MSCI Emerging Markets ETF
EEM
$28B
| $21.5K | ﹤0.01% |
315
| – | – |
|
1890
DHT Holdings
DHT
$2.97B
| $21.5K | ﹤0.01% |
1,303
| – | – |
|
1891
Birkenstock
BIRK
$7.47B
| $21.5K | ﹤0.01% |
500
+388
| +346% | +$15.7K |
|
1892
Service Corp International
SCI
$11.4B
| $21.5K | ﹤0.01% |
283
-18
| -6% | -$1.41K |
|
|
VOYG
1893
Voyager Technologies
VOYG
$1.5B
| $21.2K | ﹤0.01% |
658
+161
| +32% | +$5.57K |
|
1894
NewtekOne
NEWT
$417M
| $21.2K | ﹤0.01% |
1,429
-30
| -2% | -$396 |
|
1895
Iridium Communications
IRDM
$4.85B
| $21.1K | ﹤0.01% |
385
| – | – |
|
1896
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $21.1K | ﹤0.01% |
223
| – | – |
|
1897
Arbor Realty Trust
ABR
$960M
| $21K | ﹤0.01% |
3,869
+2,961
| +326% | +$19.2K |
|
1898
World Kinect Corp
WKC
$1.96B
| $20.9K | ﹤0.01% |
636
+289
| +83% | +$8.05K |
|
|
PR
1899
Permian Resources
PR
$17.9B
| $20.9K | ﹤0.01% |
1,136
+666
| +142% | +$13.4K |
|
1900
Heritage Financial
HFWA
$1.24B
| $20.9K | ﹤0.01% |
706
+265
| +60% | +$7.29K |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.